Association between atopic dermatitis burden and sociodemographic index with dupilumab and tralokinumab utilization across 50 countries

Int J Dermatol. 2024 Oct 31. doi: 10.1111/ijd.17543. Online ahead of print.

Authors

Arbie Sofia P Merilleno¹, Mina Tadrous², Inna Ushcatz^{1

3}, Heather J Zhao^{1

3}, Aaron M Drucker^{1

4}

Affiliations

¹ Research and Innovation Institute and Department of Medicine, Women's College Hospital, Toronto, ON, Canada.
² Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
³ Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
⁴ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

PMID: 39482808
DOI: 10.1111/ijd.17543

No abstract available

Keywords: atopic dermatitis; biologics; disease burden; dupilumab; tralokinumab.

Publication types

Letter